Stem Cell Research (Jun 2023)

Generation of a set of induced pluripotent stem cell lines from two Alzheimer disease patients carrying APOE4 (MLUi007-J; MLUi008-A) and healthy old donors carrying APOE3 (MLUi009-A; MLUi010-B) to study APOE in aging and disease

  • Matthias Jung,
  • Carla Hartmann,
  • Toni Ehrhardt,
  • Lisa-Maria Peter,
  • Chaudhry Luqman Abid,
  • Bernadette Harwardt,
  • Jana Hirschfeld,
  • Claudia Claus,
  • Undine Haferkamp,
  • Ole Pless,
  • Marina Nastainczyk-Wulf,
  • Astrid Kehlen,
  • Dietmar Schlote,
  • Insa S. Schroder,
  • Dan Rujescu

Journal volume & issue
Vol. 69
p. 103072

Abstract

Read online

Late-onset Alzheimer disease (LOAD) is the most frequent neurodegenerative disease, and the APOE ε4 allele is the most prominent risk factor for LOAD. Four human induced pluripotent stem cell (iPSC) lines MLUi007-J, MLUi008-B, MLUi009-A, and MLUi010-B were generated from LOAD patients and healthy matched donors by reprogramming of B-lymphoblastoid cells (B-LCLs) with episomal plasmids. The application of B-LCLs holds a great promise to model LOAD and other diseases because they can easily be generated from primary peripheral blood mononuclear cells (PBMCs) by infection with the Epstein-Barr virus (EBV).